How short aerobic workouts affect tumor cells in breast cancer survivors
Official title: Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity (TCReX) No: RSU/LSPA-PA-2024/1-0004 is Financed by the Investment of the European Union Recovery and Resilience Facility and the State Budget Within the Project "RSU Internal and RSU With LASE External Consolidation" No. 5.2.1.1.i.0/2/24/I/CFLA/005.
Run by Riga Stradins University · NCT07439458 · Data updated 2026-11-12
This will test whether a single session of moderate or high intensity aerobic exercise changes circulating myokines and tumor cell responses in premenopausal women who survived stage II–III triple‑negative breast cancer compared with matched healthy women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years and up |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Riga Stradins University Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Riga, Dzirciema Street 16) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | March 31, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07439458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are premenopausal women with stage II–III triple‑negative breast cancer who are 3–9 months post‑surgery/chemotherapy/radiation/immunotherapy and have cardiologist clearance including echocardiography.
✕Probably not a fit
Women who are pregnant, have autoimmune, endocrine, or cardiovascular diseases, have another cancer diagnosis, or are not medically cleared for exercise are excluded and unlikely to gain from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol compares the immediate biological effects of one session of moderate‑intensity versus high‑intensity continuous aerobic exercise on blood‑borne factors and tumor cell behavior. Premenopausal women who survived stage II–III triple‑negative breast cancer (3–9 months after completing treatment) and matched healthy control women will undergo cardiologist‑cleared exercise testing and supervised exercise sessions. Blood samples collected before and after exercise will be analyzed for myokine responses and applied to breast cancer cell lines to measure changes in tumor cell viability and signaling. The work will be performed at the Laboratory of Sports and Nutrition Research at Riga Stradins University.
Why it matters
Potential benefit: If successful, the results could identify specific exercise intensities that trigger anti‑cancer biological signals and help tailor post‑treatment exercise programs for survivors.
How similar studies have gone: Preclinical studies and early human translational work suggest exercise‑induced myokines can influence cancer cell biology, but direct human-to‑cell‑line data after acute exercise are limited and this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (intervention group): * Reproductive age (premenopausal); * Diagnosis of Stage II-III Triple-Negative Breast Cancer (TNBC) (negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)); * Timeframe of 3 to 9 months after completion of surgery, adjuvant chemotherapy, radiation therapy, and/or immunotherapy; * Physician-certified (cardiologist) physical fitness for exercise testing, supported by echocardiography (ECHO). Inclusion Criteria (control group): * Reproductive age (premenopausal); * No current or prior diagnosis of any type of cancer; * Matched by age, body constitution, and physical fitness to the breast cancer participant group. Exclusion Criteria: * Pregnancy; * Autoimmune diseases (e.g., thyroiditis, inflammatory bowel disease, atopic dermatitis, etc.); * Endocrine disorders (e.g., metabolic syndrome, diabetes); * Cardiovascular diseases; * Diagnosis of any other type of oncological disease; * Any condition for which physical activity is contraindicated (e.g., asthma, COPD, spinal disc herniation, severe iron deficiency anemia).
Where it's running
-
Laboratory of Sports and Nutrition Research
Riga, Dzirciema Street 16, Latvia Recruiting
Study contacts
- Study coordinator: Dace Reihmane, PhD
- Email: Dace.Reihmane@rsu.lv
- Phone: +37126032249
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endothelial Function in Healthy Women Over 50 See How Your Blood Vessels Work
This study tests whether flow-mediated dilation (FMD) measurements in healthy women aged 50 and older can establish reference values.
-
Acute Endocrine Responses to Aerobic vs. Anaerobic Exercise in Sedentary Young Women
This study tests how thyroid hormones and cortisol change after aerobic versus anaerobic exercise in sedentary women aged 18-25.
-
Daily Upgrade: Can an essential amino acid supplement help active women improve body composition and metabolism?
This study tests whether Daily Upgrade EAA+ helps healthy, active women by comparing it with whey protein and placebo before HIIT, and by using it daily for three weeks with twice-weekly HIIT workouts.
-
Exergames-acceptance and Commitment Therapy for Breast Cancer Depression and Anxiety
This trial tests whether a combined exergame-based program with acceptance and commitment therapy helps reduce depression and anxiety in breast cancer survivors compared with ACT alone or standard care.
-
Polarized light therapy to reduce radiation dermatitis in breast cancer patients
Aly randomized trial will test whether adding polarized light therapy to standard skin care can lessen radiation dermatitis in women receiving hypofractionated whole-breast radiotherapy.
-
Home-based ear vagus nerve stimulation for breast cancer pain and symptoms
This trial will test whether a handheld at-home transcutaneous auricular vagus nerve stimulation (taVNS) device can reduce pain and other symptoms in breast cancer survivors with ongoing moderate pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.